WHO ICTRP trial
A cohort study on practical treatment combined with bevacizumab in patients with…
JPRN-UMIN000004609 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000004609 |
|---|---|
| Public title | A cohort study on practical treatment combined with bevacizumab in patients with non-small cell lung cancer (NSCLC) excluding squamous cell lung cancer |
| Scientific title | A cohort study on practical treatment combined with bevacizumab in patients with non-small cell lung cancer (NSCLC) excluding squamous cell lung cancer - A cohort study on bevacizumab combined treatment for non-squamous NSCLC |
| Primary sponsor | Shinjuku Thoracic Oncology Group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Phase IV |
| Countries | Japan |
| Conditions | Stage IIIB or IV; locally advanced, metastatic, or recurrent non-squamous non small cell lung cancer |
| Registration date | Jan 12, 2010 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: